Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC) Meeting Abstract
| Authors: | O'Reilly, E. M.; Lowery, M. A.; Segal, M. F.; Smith, S. C.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; Salo-Mullen, E. E.; Hollywood, E.; Epstein, A. S.; Capanu, M.; Moynahan, M. E.; Fusco, A.; Stadler, Z. K.; Do, R. K. G.; Chen, A. P.; Yu, K. H.; Tang, L. H.; Kelsen, D. P. |
| Abstract Title: | Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203186 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.4023 |
| Notes: | Meeting Abstract: 4023 -- Source: Wos |
